Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease

20 Dec 2021

Abstract excerpt

This study aimed to explore the N6-methyladenosine (m6A) modification genes involved in the pathogenesis of Parkinson’s disease (PD) through data analysis of the two data sets GSE120306 and GSE22491 in the GEO database and further explore its influence on cell phenotype in PD. We analyzed the differentially expressed genes and function enrichment analysis of the two sets of data and found that the expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer-related molecular mechanisms research
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34966539
DOI: 10.1155/2021/9919129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s DiseasePMID 34966539Read ↗

Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population.Semantic proximity Read ↗

Genome-wide identification of m6A-associated single-nucleotide polymorphisms in Parkinson's disease.Semantic proximity Read ↗

Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions of Parkinson’s diseaseSemantic proximity Read ↗

Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease.Semantic proximity Read ↗

Epitranscriptome Changes in Neurodegenerative Diseases and the Potential Strategy for the TherapeuticsSemantic proximity Read ↗

Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.Semantic proximity Read ↗

Genome-wide identification of m6A-associated single nucleotide polymorphisms in complex diseases of nervous system.Semantic proximity Read ↗

WGCNA and multiple machine learning methods identified SV2C and DENR as novel biomarkers for Parkinson's diseaseSemantic proximity Read ↗

Exploring sphingolipid metabolism-related biomarkers for Parkinson’s disease: a transcriptomic analysisSemantic proximity Read ↗

Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics AnalysisSemantic proximity Read ↗

Correcting Differential Gene Expression Analysis for Cyto-Architectural Alterations in Substantia Nigra of Parkinson's Disease Patients Reveals Known and Potential Novel Disease-Associated Genes and Pathways.Semantic proximity Read ↗

Parkinson’s Disease as a Risk Factor for Prostate Adenocarcinoma: A Molecular Point of ViewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.